Adebowale J Adeniran

Best practice of BRAF V600E mutation testing for the diagnosis and management of thyroid cancers

Adebowale J Adeniran, P. Hui, Adebowale J. Adeniran, 2014, Expert review of endocrinology & metabolism.

Thyroid

Adebowale J Adeniran, 2019, Rapid On-site Evaluation (ROSE).

Acknowledgement to Reviewers

J. Fregnani, Z. Baloch, Prabodh K. Gupta, 2014, Acta Cytologica.

Translocation renal cell carcinoma

P. Argani, J. Hicks, A. D. De Marzo, 2008, Cancer.

Tall cell variant of papillary thyroid microcarcinoma: clinicopathologic features with BRAF(V600E) mutational analysis.

C. Sasaki, S. Roman, W. Westra, 2013, Thyroid : official journal of the American Thyroid Association.

Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study.

M. Prasad, T. Carling, Adebowale J Adeniran, 2011, Thyroid : official journal of the American Thyroid Association.

A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial

I. Thompson, C. Tangen, B. Shuch, 2021, The Lancet.

High WHO/ISUP Grade and Unfavorable Architecture, Rather Than Typing of Papillary Renal Cell Carcinoma, May Be Associated With Worse Prognosis

P. Humphrey, B. Shuch, H. Kluger, 2020, The American journal of surgical pathology.